Molecular identification of Spirometra erinaceieuropaei tapeworm in cases of human Sparganosis, Hong Kong.
Sparganosis is an emerging zoonotic disease and public health challenge in China, potentially because of the practice of consuming wild frog meat, which is a delicacy in the southern Guangdong province. According to a 2009 survey, >25% of the local wild frogs were infected with spargana (2). Most cases of human sparganosis have been found in Asia, with the highest cumulative number in China (online Technical Appendix Table, https://wwwnc. cdc.gov/EID/article/23/4/16-0791-Techapp1.pdf) (3). In Hong Kong, the earliest known cases of sparganosis were 2 subcutaneous infections reported in 1962 (4), and cases afterward have been sporadic. With advances in molecular sequencing, the identification of sparganum larvae isolated from humans was made possible (5,6). In this study, we performed molecular sequencing on archived histologic specimens to delineate the parasites down to species level.
Cases of human sparganosis were identified by searching the clinical, parasitologic, and histopathologic records in the Queen Elizabeth Hospital and the Pamela Youde Nethersole Eastern Hospital in Hong Kong. Archived histopathology specimens showing parasites compatible with plerocercoids were retrieved for further molecular testing. We made 10-15 (depending on the amount of tissue available) 4-[micro]m sections from each paraffin block; the sections were deparaffinized and suspended in sterile, normal saline. Genomic DNA was extracted from formalin-fixed paraffin-embedded tissue by using a DNA minikit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. The DNA was eluted in 60[micro]L of elution buffer and used as template for PCR.
Primer sequences used in this study were cox1-F 5'-CGGCTTTTTTTGATCCTTTGGGTGG-3', cox1R 5'-GTATCATATGAACAACCTAATTTAC-3', 28S-F 5'-CACCGAAGC CTGCGGTA-3', and 28S-R 5'-GAAGGTCGACCTGGTGAA-3', which targeted specifically to the cox1 and 28S rRNA genes of S. erinaceieuropaei respectively (7). The later primers were designed in-house by multiple alignments of different parasite species. The PCR mixture (25[micro]L) contained DNA, PCR buffer (10 mmol/L Tris-HCl [pH 8.3], 50 mmol/L KCl, 3 mmol/L Mg[Cl.sub.2], and 0.01% gelatin), and 200 mmol/L each deoxynucleoside triphosphate (dNTP) and 1.0 U Taq polymerase (Applied Biosystems, Foster City, CA, USA). The mixtures were amplified in 60 cycles of 94[degrees]C for 1 min, 55[degrees]C for 1 min, and 72[degrees]C for 1 min with a final extension at 72[degrees]C for 10 min in an automated thermal cycler (Applied Biosystems). Standard precautions were taken to avoid PCR contamination, and no false-positive results were observed in negative controls. PCR products were gel purified by using the QIAquick gel extraction kit (QIAGEN). Both strands of the PCR products were sequenced twice with an ABI Prism 3700 DNA analyzer (Applied Biosystems). Sequences of the PCR products were compared with known sequences by BLAST analysis (https://blast.ncbi.nlm.nih.gov).
We constructed a phylogenetic tree using the neighborjoining method with Kimura's 2-parameter correction with ClustalX 1.83 (http://www.clustal.org). We included in the analysis the 252 bps and 211 bps of the amplicon from the cox1 gene (GenBank accession nos. KU760072-81) and the 28S rRNA gene (accession nos. KX831668-77) of S. erinaceieuropaei, respectively, detected in positive samples. Strongyloides stercoralis was used as the outgroup in these analyses.
Seven patients with human sparganosis were identified in Queen Elizabeth Hospital, and 2 patients were identified in the Pamela Youde Nethersole Eastern Hospital. All diagnoses were made from 1999 to 2015 (Table). Eight patients were Chinese; 1 was Filipino, and 4 were male. Patient age at diagnosis was 29-73 (median 49) years. Three patients displayed neurologic symptoms, such as numbness, weakness, or memory impairment, and the other 6 displayed skin and soft tissue involvement. All had progressively enlarging or migratory skin nodules (Table). Additional information on clinical history, histopathology, and magnetic resonance brain imaging of representative cases was collected (online Technical Appendix).
Nine patients had archived histopathologic specimens available for molecular testing. Parasite identification was achieved in all 9 specimens, and they showed 99%-100% and 100% identity with the cox1 and 28S rRNA gene sequences of S. erinaceieuropaei, respectively (Figure, panels A and B).
This study demonstrates that human sparganosis appeared sporadically in Hong Kong. The most common signs of disease were skin and soft tissue nodules followed by intracranial lesions. By molecular sequencing, the tested parasites were S. erinaceieuropaei. We were unable to pinpoint the source of infection in most patients; the incubation period can last as long as several months, and early stages of the disease are usually asymptomatic (8). Patients might have difficulty recalling specific high-risk exposures. In most industrialized countries, the practice of applying raw frog or snake poultices to open wounds is regarded as unhygienic and becoming obsolete, yet consumption of undercooked frog meat or, less commonly, ingestion of raw snake bile for medicinal purposes is still practiced in Hong Kong. Another possible route of transmission could have been drinking water contaminated with Spirometra procercoids.
Subcutaneous sparganosis is the most commonly recognized form of the disease. Because sparganosis is rare, it is seldom considered during an initial patient assessment, although a migratory nodule might raise the suspicion for a helminthic etiology. Diagnosis of sparganosis needs to be confirmed, normally by studying the excised lesions. Even though serologic tests for sparganosis have been described, these assays are not generally available and their performance requires more evaluation (9-13). In contrast, the presence of tunnel sign, conglomerated rings, bead-shaped enhancements, or images of parasites of various life stages by computerized tomography or magnetic resonance imaging are suggestive of sparganosis (14). Histopathologic diagnosis of parasitic infections remains a challenge to pathologists in countries where sparganosis is not endemic. Recognizing the different phyla and classes of parasites (i.e., nematodes, cestodes, and trematodes) histologically is usually simple. However, specific identification of the genus and species requires substantial expertise in parasite pathology and morphology. Identification of rare parasites is sometimes impossible because of the lack of detailed morphologic descriptions in the literature. Under such circumstances, molecular studies provide useful information for species identification (15). Nevertheless, it is not infallible, especially for rare parasites, because precise species identification depends on gene sequence availability and data accuracy.
Although the parasitic drug praziquantel has wide coverage against several cestodes and trematodes, its efficacy in the treatment of sparganosis remains uncertain. Surgical intervention for complete worm removal should be used whenever feasible.
This study had limitations. We only included information on patients from 2 of the 7 geographic clusters of public hospitals in Hong Kong, and those with asymptomatic subcutaneous lesions most likely did not seek medical attention. The reported number is certainly an underestimate.
Given that human sparganosis is an emerging zoonotic parasitic infection, clinicians may consider it in the differential diagnosis for mass lesions with undetermined etiology. Education of the general public about food safety, including avoiding the consumption of untreated water and undercooked frog and snake meat, is needed.
We thank Sherman Lo for providing magnetic resonance imaging brain scans.
Dr. Tang is the associate consultant of the Division of Infectious Diseases in the Department of Medicine at Queen Elizabeth Hospital. His research interests are emerging infectious diseases, infections in immunocompromised hosts, infectious disease epidemiology, and global health.
(1.) Liu Q, Li MW, Wang ZD, Zhao GH, Zhu XQ. Human sparganosis, a neglected food borne zoonosis. Lancet Infect Dis. 2015;15:1226-35. http://dx.doi.org/10.1016/S1473-3099(15)00133-4
(2.) Li MW, Lin HY, Xie WT, Gao MJ, Huang ZW, Wu JP, et al. Enzootic sparganosis in Guangdong, People's Republic of China. Emerg Infect Dis. 2009;15:1317-8. http://dx.doi.org/10.3201/ eid1508.090099
(3.) Zhang X, Cui J, Liu LN, Jiang P, Wang H, Qi X, et al. Genetic structure analysis of Spirometra erinaceieuropaei isolates from central and southern China. PLoS One. 2015;10:e0119295. http://dx.doi.org/10.1371/journal.pone.0119295
(4.) Huang CT, Kirk R. Human sparganosis in Hong Kong. J Trop Med Hyg. 1962;65:133-8.
(5.) Boonyasiri A, Cheunsuchon P, Suputtamongkol Y, Yamasaki H, Sanpool O, Maleewong W, et al. Nine human sparganosis cases in Thailand with molecular identification of causative parasite species. Am J Trop Med Hyg. 2014;91:389-93. http://dx.doi.org/10.4269/ ajtmh.14-0178
(6.) Jeon HK, Park H, Lee D, Choe S, Kim KH, Huh S, et al. Human Infections with Spirometra decipiens plerocercoids identified by morphologic and genetic analyses in Korea. Korean J Parasitol. 2015;53:299-305. http://dx.doi.org/10.3347/ kjp.2015.53.3.299
(7.) Koonmee S, Intapan PM, Yamasaki H, Sugiyama H, Muto M, Kuramochi T, et al. Molecular identification of a causative parasite species using formalin-fixed paraffin embedded (FFPE) tissues of a complicated human pulmonary sparganosis case without decisive clinical diagnosis. Parasitol Int. 2011;60:460-4. http://dx.doi.org/10.1016/j.parint.2011.07.018
(8.) Tappe D, Berger L, Haeupler A, Muntau B, Racz P, Harder Y, et al. Case report: molecular diagnosis of subcutaneous Spirometra erinaceieuropaei sparganosis in a Japanese immigrant. Am J Trop Med Hyg. 2013;88:198--202. http://dx.doi.org/10.4269/ ajtmh.2012.12-0406
(9.) Yeo IS, Yong TS, Im K. Serodiagnosis of human sparganosis by a monoclonal antibody-based competition ELISA. Yonsei Med J. 1994;35:43-8. http://dx.doi.org/10.3349/ymj.19220.127.116.11
(10.) Cui J, Li N, Wang ZQ, Jiang P, Lin XM. Serodiagnosis of experimental Sparganum infections of mice and human sparganosis by ELISA using ES antigens of Spirometra mansoni spargana. Parasitol Res. 2011;108:1551-6. http://dx.doi.org/ 10.1007/s00436-010-2206-2
(11.) Rahman SMM, Kim JH, Hong ST, Choi MH. Diagnostic efficacy of a recombinant cysteine protease of Spirometra erinacei larvae for serodiagnosis of sparganosis. Korean J Parasitol. 2014;52:41-6. http://dx.doi.org/10.3347/kjp.2014.52.1.41
(12.) Liu LN, Zhang X, Jiang P, Liu RD, Zhou J, He RZ, et al. Serodiagnosis of sparganosis by ELISA using recombinant cysteine protease of Spirometra erinaceieuropaei spargana. Parasitol Res. 2015;114:753-7. http://dx.doi.org/10.1007/ s00436-014-4270-5
(13.) Liu LN, Wang ZQ, Zhang X, Jiang P, Qi X, Liu RD, et al. Characterization of Spirometra erinaceieuropaei plerocercoid cysteine protease and potential application for serodiagnosis of sparganosis. PLoS Negl Trop Dis. 2015;9:e0003807. http://dx.doi.org/10.1371/journal.pntd.0003807
(14.) Lo Presti A, Aguirre DT, De Andres P, Daoud L, Fortes J, Muniz J. Cerebral sparganosis: case report and review of the European cases. Acta Neurochir (Wien). 2015;157:1339-43, discussion 1343. http://dx.doi.org/10.1007/s00701-015-2466-9
(15.) Wong SSY, Fung KSC, Chau S, Poon RWS, Wong SCY, Yuen KY. Molecular diagnosis in clinical parasitology: when and why? Exp Biol Med (Maywood). 2014;239:1443-60. http://dx.doi.org/10.1177/1535370214523880
Address for correspondence: Tommy H.C. Tang, Division of Infectious Diseases, Department of Medicine, Queen Elizabeth Hospital, 30 Gascoigne Rd, Hong Kong, China; email: email@example.com
Tommy H.C. Tang,  Samson S.Y. Wong,  Christopher K.C. Lai,  Rosana W.S. Poon,  Helen S.Y. Chan, Tak Chiu Wu, Yuk-Fai Cheung, Tak-Lap Poon, Yi-Po Tsang, Wai-Lun Tang, Alan K.L. Wu
Author affiliations: Queen Elizabeth Hospital, Hong Kong, China (T.H.C. Tang, C.K.C. Lai, H.S.Y. Chan, T.C. Wu, Y.-F. Cheung, T.-L. Poon); The University of Hong Kong, Hong Kong (S.S.Y. Wong, R.W.S. Poon); Pamela Youde Nethersole Eastern Hospital, Hong Kong (Y.-P. Tsang, W.-L. Tang, A.K.L. Wu)
 These first authors contributed equally to this article.
 These authors contributed equally to this article.
Caption: Figure. Phylogenetic analysis of cox1 and 28S rRNA genes of archived formalin-fixed paraffin-embedded tissues obtained from human sparganosis cases, Hong Kong, 1999-2015. A) A 252-bp sequence from the cox1 gene (GenBank accession nos. KU760072-81) was included for each isolate. B) A 211-bp sequence from the 28S rRNA gene (accession nos. KX831668-77) was included for each isolate. Trees were constructed by using the neighbor-joining method and rooted with the corresponding sequence in Strongyloides stercoralis (accession nos. AB526297.1 and U39489.1 for cox1 and 28S rRNA genes, respectively). The bootstrap values are shown for nodes that appeared in >70% of the 1,000 replicates. The species used for comparison and their GenBank accession numbers are given in the tree. Scale bars indicate estimated number of substitutions per 50 bases.
Table. Characteristics of cases of human sparganosis, Hong Kong, 1999-2015 * Probable Pt no. Year Age, Ethnicity place/mode of y/sex infection 1 1999 67/F Chinese Unk/Unk 2 2000 46/M Chinese Unk/Unk 3 2002 29/F Chinese Unk/Unk 4 2003 63/F Chinese Unk/Unk 5 2004 44/M Chinese Unk/Unk 2014 55/M Unk/Unk 6 2005 43/F Chinese Unk/Unk 7 2011 58/M Chinese China/ingestion of frogs and snakes 8 2013 49/F Filipino Unk/Unk 9 2015 73/M Chinese China/ingestion of frogs Pt no. Location Size of worm or of lesion lesion, cm 1 Right breast 0.15 x 0.1 x 0.7, 0.15 x 0.1 x 0.7, 0.1 x 0.5 x 0.5 (lesions excised) 2 NR 0.15 (worm length) 3 Epigastrium of 4 x 2.5 x 2 (lesion abdominal excised) wall 4 Left thigh 0.6 (maximum dimension of lesion excised) 5 Right thigh 1.5 x 1.5 (lesion); 0.27 x 0.2 x 0.5 (worm) Right thigh 1.6 x 1.3 x 1.4 and suspected (lesion) left frontal lobe 6 Left breast 0.21 (lesion excised) 7 Left chest wall 3 x 2.5 x 1 (lesion) 8 Left parietal 0.17 x 0.12 x 0.23 lobe (lesion) 9 Left thigh 0.5 x 0.5 x 0.1 (lesion excised) PEC, x Pt no. Clinical features [10.sup.9]/L (% total WBC count) 1 Right breast mass NR 2 NR NR 3 NR NR 4 Progressive enlarging mass NR for 2 years 5 Right thigh nodule for 6 NR months Recurrent right thigh nodule; 0.22 (3.7) suspicious 2x5x5 mm T2W/FLAIR hyperintensity with contrast enhancement in left frontal white matter 6 Progressive enlarging left 0.1 (0.7) breast mass 7 Left chest wall mass for 3 0.21 (2.5) years 8 Right-sided numbness and 0.1 (1.1) weakness for 2 days 9 Progressive enlarging left 0.21 (4.2) inner thigh mass for 1 year * All worms were identified as Spirometra erinaceieuropaei. NR, not recorded; PEC, peripheral eosinophil count; Pt, patient; T2W/FLAIR, T2-weighted/fluid attenuation inversion recovery; Unk, unknown; WBC, white blood cell.
|Printer friendly Cite/link Email Feedback|
|Author:||Tang, Tommy H.C.; Wong, Samson S.Y.; Lai, Christopher K.C.; Poon, Rosana W.S.; Chan, Helen S.Y.; Wu,|
|Publication:||Emerging Infectious Diseases|
|Date:||Apr 1, 2017|
|Previous Article:||Markers of disease severity in patients with Spanish influenza in the Japanese Armed Forces, 1919-1920.|
|Next Article:||Zika virus seroprevalence, French Polynesia, 2014-2015.|